Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide with or without Oseltamivir in Acute Uncomplicated Influenza
2013-003933-14Phase 3Completed
- Sponsor
- Romark Laboratories
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitazoxanide in influenza (3 arms), sponsored by Romark Laboratories. Primary endpoint: Time to alleviation of all clinical symptoms of influenza. Started Oct 2013; status: completed.
02
Drugs
nitazoxanide
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-003933-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003933-14.